SI0984773T1 - Pharmaceutical formulation of omeprazole - Google Patents

Pharmaceutical formulation of omeprazole

Info

Publication number: SI0984773T1
Authority: SI; Slovenia
Prior art keywords: omeprazole; pharmaceutical formulation; formulation; pharmaceutical
Prior art date: 1997-05-28

Application number

SI9830433T

Other languages

English (en)

Slovenian (sl)

Inventor

Magnus Erickson

Lars Josefsson

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-28

Filing date

1998-05-18

Publication date

2003-10-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20407122&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI0984773(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-05-18 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2003-10-31 Publication of SI0984773T1 publication Critical patent/SI0984773T1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

SI9830433T 1997-05-28 1998-05-18 Pharmaceutical formulation of omeprazole SI0984773T1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE9702000A SE9702000D0 (sv)	1997-05-28	1997-05-28	New pharmaceutical formulation
EP98924700A EP0984773B1 (en)	1997-05-28	1998-05-18	Pharmaceutical formulation of omeprazole
PCT/SE1998/000922 WO1998053803A1 (en)	1997-05-28	1998-05-18	Pharmaceutical formulation of omeprazole

Publications (1)

Publication Number	Publication Date
SI0984773T1 true SI0984773T1 (en)	2003-10-31

Family

ID=20407122

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI9830433T SI0984773T1 (en)	1997-05-28	1998-05-18	Pharmaceutical formulation of omeprazole

Country Status (40)

Country	Link
US (1)	US6090827A (uk)
EP (1)	EP0984773B1 (uk)
JP (1)	JP4649001B2 (uk)
KR (1)	KR100540721B1 (uk)
CN (1)	CN1123338C (uk)
AR (1)	AR012698A1 (uk)
AT (1)	ATE234078T1 (uk)
AU (1)	AU722879B2 (uk)
BR (1)	BR9809484A (uk)
CA (1)	CA2290531C (uk)
CZ (1)	CZ298972B6 (uk)
DE (1)	DE69812089T2 (uk)
DK (1)	DK0984773T3 (uk)
DZ (1)	DZ2494A1 (uk)
EE (1)	EE03903B1 (uk)
EG (1)	EG24044A (uk)
ES (1)	ES2195342T3 (uk)
HR (1)	HRP980260B1 (uk)
HU (1)	HU229154B1 (uk)
ID (1)	ID24654A (uk)
IL (1)	IL132895A0 (uk)
IS (1)	IS2856B (uk)
MA (1)	MA26497A1 (uk)
MY (1)	MY122298A (uk)
NO (1)	NO328100B1 (uk)
NZ (1)	NZ500886A (uk)
PL (1)	PL194634B1 (uk)
PT (1)	PT984773E (uk)
RS (1)	RS49629B (uk)
RU (1)	RU2207121C2 (uk)
SA (1)	SA98190304B1 (uk)
SE (1)	SE9702000D0 (uk)
SI (1)	SI0984773T1 (uk)
SK (1)	SK286625B6 (uk)
TN (1)	TNSN98068A1 (uk)
TR (1)	TR199902890T2 (uk)
TW (1)	TW575435B (uk)
UA (1)	UA71541C2 (uk)
WO (1)	WO1998053803A1 (uk)
ZA (1)	ZA984178B (uk)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6489346B1 (en)	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
US6699885B2 (en)	1996-01-04	2004-03-02	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en)	1996-01-04	2003-11-11	Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US6096340A (en)	1997-11-14	2000-08-01	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
US6174548B1 (en) *	1998-08-28	2001-01-16	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
KR100627614B1 (ko) *	1998-04-20	2006-09-25	에자이 가부시키가이샤	안정화된 벤즈이미다졸계 화합물 함유 조성물로 이루어지는 의약제제
SE9803772D0 (sv)	1998-11-05	1998-11-05	Astra Ab	Pharmaceutical formulation
SE9902386D0 (sv) *	1999-06-22	1999-06-22	Astra Ab	New formulation
US6245913B1 (en)	1999-06-30	2001-06-12	Wockhardt Europe Limited	Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
ES2168043B1 (es)	1999-09-13	2003-04-01	Esteve Labor Dr	Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
DE60036014T2 (de)	1999-10-20	2008-04-30	Eisai R&D Management Co., Ltd.	Methode zur stabilisierung von benzimidazol-verbindungen
US20040092511A1 (en) *	1999-12-10	2004-05-13	Billstein Stephan Anthony	Pharmaceutical combinations and their use in treating gastrointestinal and abdominal viscera disorders
US20020192299A1 (en) *	2000-12-28	2002-12-19	Rajneesh Taneja	Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
JP2002234842A (ja) *	2001-02-09	2002-08-23	Kyowa Yakuhin Kogyo Kk	内服腸溶性製剤
EP1469839A2 (en) *	2002-01-25	2004-10-27	Santarus, Inc.	Transmucosal delivery of proton pump inhibitors
US20040082618A1 (en) *	2002-07-03	2004-04-29	Rajneesh Taneja	Liquid dosage forms of acid labile drugs
FR2843121B3 (fr)	2002-08-02	2004-09-10	Rhodia Chimie Sa	Agent ignifugeant, procede de preparation et l'utilisation de cet agent
US20070243251A1 (en) *	2002-12-20	2007-10-18	Rajneesh Taneja	Dosage Forms Containing A PPI, NSAID, and Buffer
US20040121004A1 (en) *	2002-12-20	2004-06-24	Rajneesh Taneja	Dosage forms containing a PPI, NSAID, and buffer
US20040146558A1 (en) *	2003-01-28	2004-07-29	Kyowa Pharmaceutical Co., Ltd.	Oral enteric-coated preparation
JP4567340B2 (ja) *	2003-01-29	2010-10-20	武田薬品工業株式会社	被覆製剤の製造方法
RU2359671C2 (ru) *	2003-01-29	2009-06-27	Такеда Фармасьютикал Компани Лимитед	Способ получения препарата с покрытием
PL377403A1 (pl)	2003-01-29	2006-02-06	Takeda Pharmaceutical Company Limited	Sposób wytwarzania preparatu powlekanego
UA86015C2 (uk) *	2003-01-29	2009-03-25	Такеда Фармасьютикал Компани Лимитед	Спосіб одержання твердої лікарської форми з покриттям
CA2517005A1 (en) *	2003-02-20	2004-09-02	Santarus, Inc.	A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
RU2375048C2 (ru) *	2003-07-17	2009-12-10	Д-Р Редди'С Лабораторис Инк.	Фармацевтическая композиция с набухающим покрытием
US8993599B2 (en)	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070292498A1 (en) *	2003-11-05	2007-12-20	Warren Hall	Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
CN1311824C (zh) *	2004-04-21	2007-04-25	常州市第四制药厂有限公司	奥美拉唑肠溶微粒制剂及制备方法
US8906940B2 (en) *	2004-05-25	2014-12-09	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) *	2004-05-25	2014-08-26	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
DE602005013372D1 (de) *	2005-07-29	2009-04-30	Rottapharm Spa	Kombination aus Itriglumid und PPI zur Behandlung von gastrointestinalen- und assozierten Krankheiten
JP2009538901A (ja) *	2006-06-01	2009-11-12	デクセルファーマテクノロジーズエルティーディー．	複式ユニット製薬的製剤
KR101436516B1 (ko) *	2007-07-23	2014-09-02	주식회사태평양제약	코팅된 펠렛을 함유하는 현탁정 및 이의 제조방법
CA2704132A1 (en) *	2007-09-28	2009-04-02	Ctc Bio, Inc.	Pharmaceutical composition containing esomeprazole
HUE028919T2 (en) *	2008-03-28	2017-01-30	Ferrer Int	Capsules for preventing cardiovascular diseases
NZ590746A (en)	2008-08-19	2012-10-26	Xenoport Inc	Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
JP2015527372A (ja)	2012-08-22	2015-09-17	ゼノポート，インコーポレイティド	副作用を低減させるモノメチルフマレートおよびそのプロドラッグの投与方法
JP2015526476A (ja)	2012-08-22	2015-09-10	ゼノポート，インコーポレイティド	メチル水素フマレートの経口剤形およびそのプロドラッグ
CN102961356A (zh) *	2012-12-11	2013-03-13	山西云鹏制药有限公司	一种含奥美拉唑的蓝色肠溶片剂的制备方法
US10179118B2 (en)	2013-03-24	2019-01-15	Arbor Pharmaceuticals, Llc	Pharmaceutical compositions of dimethyl fumarate
JP2016534133A (ja)	2013-09-06	2016-11-04	ゼノポート，インコーポレイティド	（ｎ，ｎ−ジエチルカルバモイル）メチルメチル（２ｅ）ブト−２−エン−１，４−ジオエートの結晶形態、その合成方法及び使用
WO2015042294A1 (en) *	2013-09-18	2015-03-26	Xenoport, Inc.	Nanoparticle compositions of dimethyl fumarate
US9999672B2 (en)	2014-03-24	2018-06-19	Xenoport, Inc.	Pharmaceutical compositions of fumaric acid esters
WO2016174664A1 (en)	2015-04-29	2016-11-03	Dexcel Pharma Technologies Ltd.	Orally disintegrating compositions
US10076494B2 (en)	2016-06-16	2018-09-18	Dexcel Pharma Technologies Ltd.	Stable orally disintegrating pharmaceutical compositions
US20230058473A1 (en)	2020-01-27	2023-02-23	Towa Pharmaceutical Co., Ltd.	Esomeprazole oral preparation and method for producing the same
KR102432084B1 (ko)	2021-11-16	2022-08-12	알리코제약(주)	S-오메프라졸을 함유하는 안정성이 개선되고 소형화된 정제
WO2024075017A1 (en)	2022-10-04	2024-04-11	Zabirnyk Arsenii	Inhibition of aortic valve calcification

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE7804231L (sv) *	1978-04-14	1979-10-15	Haessle Ab	Magsyrasekretionsmedel
SE8301182D0 (sv) *	1983-03-04	1983-03-04	Haessle Ab	Novel compounds
GB2189698A (en) *	1986-04-30	1987-11-04	Haessle Ab	Coated omeprazole tablets
YU48263B (sh) *	1991-06-17	1997-09-30	Byk Gulden Lomberg Chemische Fabrik Gmbh.	Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
JPH05255088A (ja) *	1991-11-05	1993-10-05	Yoshitomi Pharmaceut Ind Ltd	抗潰瘍剤含有製剤
JP2669446B2 (ja) *	1992-03-23	1997-10-27	信越化学工業株式会社	医薬品コーティング液用原料粉粒体
FR2692146B1 (fr) *	1992-06-16	1995-06-02	Ethypharm Sa	Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
JPH0733659A (ja) *	1992-07-17	1995-02-03	Yoshitomi Pharmaceut Ind Ltd	抗潰瘍剤含有製剤
SE9301830D0 (sv) *	1993-05-28	1993-05-28	Ab Astra	New compounds
SE9302396D0 (sv) *	1993-07-09	1993-07-09	Ab Astra	A novel compound form
SE9302395D0 (sv) *	1993-07-09	1993-07-09	Ab Astra	New pharmaceutical formulation
AU695966B2 (en) *	1994-07-08	1998-08-27	Astrazeneca Ab	Multiple unit tableted dosage form I
SE9500422D0 (sv) *	1995-02-06	1995-02-06	Astra Ab	New oral pharmaceutical dosage forms

1997
- 1997-05-28 SE SE9702000A patent/SE9702000D0/xx unknown
1998
- 1998-05-14 AR ARP980102246A patent/AR012698A1/es not_active Application Discontinuation
- 1998-05-14 HR HR980260A patent/HRP980260B1/xx not_active IP Right Cessation
- 1998-05-15 TW TW87107541A patent/TW575435B/zh not_active IP Right Cessation
- 1998-05-15 MA MA25077A patent/MA26497A1/fr unknown
- 1998-05-18 TR TR1999/02890T patent/TR199902890T2/xx unknown
- 1998-05-18 US US09/077,717 patent/US6090827A/en not_active Expired - Lifetime
- 1998-05-18 JP JP50056299A patent/JP4649001B2/ja not_active Expired - Fee Related
- 1998-05-18 ES ES98924700T patent/ES2195342T3/es not_active Expired - Lifetime
- 1998-05-18 EE EEP199900540A patent/EE03903B1/xx not_active IP Right Cessation
- 1998-05-18 CA CA002290531A patent/CA2290531C/en not_active Expired - Lifetime
- 1998-05-18 ID IDW991448A patent/ID24654A/id unknown
- 1998-05-18 CZ CZ0420299A patent/CZ298972B6/cs not_active IP Right Cessation
- 1998-05-18 BR BR9809484-0A patent/BR9809484A/pt not_active Application Discontinuation
- 1998-05-18 IL IL13289598A patent/IL132895A0/xx not_active IP Right Cessation
- 1998-05-18 RS YUP-608/99A patent/RS49629B/sr unknown
- 1998-05-18 UA UA99116247A patent/UA71541C2/uk unknown
- 1998-05-18 AU AU76803/98A patent/AU722879B2/en not_active Ceased
- 1998-05-18 WO PCT/SE1998/000922 patent/WO1998053803A1/en active IP Right Grant
- 1998-05-18 SI SI9830433T patent/SI0984773T1/xx unknown
- 1998-05-18 HU HU0002182A patent/HU229154B1/hu not_active IP Right Cessation
- 1998-05-18 DZ DZ980104A patent/DZ2494A1/xx active
- 1998-05-18 SK SK1590-99A patent/SK286625B6/sk not_active IP Right Cessation
- 1998-05-18 DK DK98924700T patent/DK0984773T3/da active
- 1998-05-18 DE DE69812089T patent/DE69812089T2/de not_active Expired - Lifetime
- 1998-05-18 PL PL98337237A patent/PL194634B1/pl unknown
- 1998-05-18 EP EP98924700A patent/EP0984773B1/en not_active Expired - Lifetime
- 1998-05-18 ZA ZA984178A patent/ZA984178B/xx unknown
- 1998-05-18 NZ NZ500886A patent/NZ500886A/en not_active IP Right Cessation
- 1998-05-18 CN CN98805564A patent/CN1123338C/zh not_active Expired - Fee Related
- 1998-05-18 PT PT98924700T patent/PT984773E/pt unknown
- 1998-05-18 AT AT98924700T patent/ATE234078T1/de active
- 1998-05-18 RU RU99126869/14A patent/RU2207121C2/ru not_active IP Right Cessation
- 1998-05-18 KR KR1019997011083A patent/KR100540721B1/ko not_active Expired - Fee Related
- 1998-05-21 TN TNTNSN98068A patent/TNSN98068A1/fr unknown
- 1998-05-25 EG EG56898A patent/EG24044A/xx active
- 1998-05-27 MY MYPI98002355A patent/MY122298A/en unknown
- 1998-07-19 SA SA98190304A patent/SA98190304B1/ar unknown
1999
- 1999-11-11 IS IS5245A patent/IS2856B/is unknown
- 1999-11-26 NO NO19995809A patent/NO328100B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
IS5245A (is)	1999-11-11
DE69812089D1 (de)	2003-04-17
AR012698A1 (es)	2000-11-08
NZ500886A (en)	2001-11-30
DK0984773T3 (da)	2003-07-07
NO995809L (no)	2000-01-28
CA2290531A1 (en)	1998-12-03
HRP980260B1 (en)	2003-10-31
CN1123338C (zh)	2003-10-08
IL132895A0 (en)	2001-03-19
SK159099A3 (en)	2000-06-12
JP4649001B2 (ja)	2011-03-09
ATE234078T1 (de)	2003-03-15
AU7680398A (en)	1998-12-30
ID24654A (id)	2000-07-27
EG24044A (en)	2008-04-13
KR20010013104A (ko)	2001-02-26
HRP980260A2 (en)	1999-02-28
MY122298A (en)	2006-04-29
SK286625B6 (sk)	2009-02-05
US6090827A (en)	2000-07-18
PL337237A1 (en)	2000-08-14
EE03903B1 (et)	2002-12-16
HUP0002182A2 (hu)	2002-05-29
CZ298972B6 (cs)	2008-03-26
CN1258217A (zh)	2000-06-28
PT984773E (pt)	2003-07-31
HU229154B1 (en)	2013-09-30
AU722879B2 (en)	2000-08-10
TW575435B (en)	2004-02-11
HUP0002182A3 (en)	2003-02-28
EP0984773B1 (en)	2003-03-12
NO328100B1 (no)	2009-12-07
IS2856B (is)	2013-11-15
UA71541C2 (uk)	2004-12-15
HK1025744A1 (en)	2000-11-24
EP0984773A1 (en)	2000-03-15
RS49629B (sr)	2007-08-03
SA98190304B1 (ar)	2006-10-11
KR100540721B1 (ko)	2006-01-10
YU60899A (sh)	2002-06-19
SE9702000D0 (sv)	1997-05-28
ES2195342T3 (es)	2003-12-01
CA2290531C (en)	2006-12-12
DE69812089T2 (de)	2004-03-04
ZA984178B (en)	1998-11-30
TR199902890T2 (xx)	2000-02-21
NO995809D0 (no)	1999-11-26
PL194634B1 (pl)	2007-06-29
MA26497A1 (fr)	2004-12-20
RU2207121C2 (ru)	2003-06-27
DZ2494A1 (fr)	2003-01-25
WO1998053803A1 (en)	1998-12-03
BR9809484A (pt)	2000-06-20
TNSN98068A1 (fr)	2005-03-15
CZ420299A3 (cs)	2000-05-17
JP2002500665A (ja)	2002-01-08
EE9900540A (et)	2000-06-15

Publication	Publication Date	Title
EG24044A (en)	2008-04-13	pharmaceutical formulation of omeprazole
EP1030654A4 (en)	2002-05-02	PREPARATION OF OMEPRAZOLE
HUP0004534A3 (en)	2002-10-28	Pharmaceutical formulation containing olanzapine
GB9713149D0 (en)	1997-08-27	Pharmaceutical formulations
IL131201A0 (en)	2001-01-28	Pharmaceutical formulations comprising amoxocyllin and clavulanate
ZA982872B (en)	1998-10-12	Pharmaceutical formulation
HUP0100178A3 (en)	2002-12-28	Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof
HUP0001243A3 (en)	2000-10-30	Nicotinamide derivatives and pharmaceutical compositions containing them
IL133420A0 (en)	2001-04-30	Pharmaceutical composition for combination of piperidinoalkanol-decongestant
HUP0001309A3 (en)	2000-12-28	1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them
HUP0002324A3 (en)	2001-07-30	Benzimidazole derivatives and pharmaceutical compositions containing them
HUP9800147A3 (en)	1999-01-28	Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them
HUP0100085A3 (en)	2002-12-28	Biphenylamidine derivatives and pharmaceutical compositions containing them
HUP0002331A3 (en)	2001-05-28	20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
HUP0101701A3 (en)	2003-02-28	Substituted betha-alanines and pharmaceutical compositions comprising them
GB9700737D0 (en)	1997-03-05	Administration of drugs
HUP0001010A3 (en)	2001-06-28	Benzimidazole derivatives and pharmaceutical compositions containing them
GB9818927D0 (en)	1998-10-21	Pharmaceutical formulation
GB9709739D0 (en)	1997-07-02	Pharmaceutical formulation
GB9822333D0 (en)	1998-12-09	Pharmaceutical formulation
GB9817470D0 (en)	1998-10-07	Pharmaceutical formulation
GB9802617D0 (en)	1998-04-01	Pharmaceutical formulation
SI1124539T1 (en)	2003-12-31	Pharmaceutical formulation comprising omeprazole
HUP0003827A3 (en)	2001-09-28	Cyanoamidine derivatives and pharmaceutical compositions containing them
HUP0004274A3 (en)	2002-03-28	Bispyrido-cycloheptane compounds and pharmaceutical compositions thereof